Back to User profile » Dr Sofia Lampaki

Papers published by Dr Sofia Lampaki:


An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece

Mountzios G, Lampaki S, Koliou GA, Vozikis A, Kontogiorgos I, Papantoniou P, Koufaki MI, Res E, Boutis A, Christopoulou A, Pastelli N, Grivas A, Aravantinos G, Lalla E, Oikonomopoulos G, Koumarianou A, Spyratos D, Bafaloukos Snr D, Rigakos G, Papakotoulas P, Fountzilas G, Linardou H

Lung Cancer: Targets and Therapy 2021, 12:93-102

Published Date: 30 August 2021

Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges

Spyratos D, Papadaki E, Lampaki S, Kontakiotis T

Lung Cancer: Targets and Therapy 2017, 8:101-107

Published Date: 7 August 2017

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment

Pitsiou G, Zarogoulidis P, Petridis D, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Papaiwannou A, Tsiouda T, Hohenforst-Schmidt W, Kakolyris S, Syrigos K, Huang H, Li Q, Turner JF, Zarogoulidis K

Drug Design, Development and Therapy 2014, 8:1753-1763

Published Date: 7 October 2014